Stay updated on Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-28T15:46:50.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates about the terminology transition from “Artificial Intelligence” to “Super Intelligence.” The study page itself continues to show a 403 error.
    Difference
    1%
    Check dated 2026-10-21T20:39:40.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2, while the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-14T20:33:24.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The error page’s displayed site revision was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T20:47:16.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header and a Home link, replacing the study record content with an access-block notice.
    Difference
    19%
    Check dated 2026-09-23T21:01:41.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0. This indicates a new build of the page content and does not change the trial details themselves.
    Difference
    0.1%
    Check dated 2026-09-16T22:09:13.000Z thumbnail image

Stay in the know with updates to Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.